Polar Asset Management Partners Inc. Acquires Shares of 77,592 Agilent Technologies, Inc. $A

Key Points

• Polar Asset Management Partners Inc. has acquired a new stake in Agilent Technologies, purchasing 77,592 shares valued at approximately $9.08 million.
• Various institutional investors have increased their holdings in Agilent Technologies, with significant transactions from Sunbelt Securities Inc. and Whipplewood Advisors LLC reflecting strong interest in the company.
• Agilent Technologies reported earnings of $1.37 per share for the last quarter, meeting analysts' expectations, alongside total revenue of $1.74 billion, which represents a 10.1% year-over-year increase.

Polar Asset Management Partners Inc. acquired a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 77,592 shares of the medical research company's stock, valued at approximately $9,077,000.

Several other institutional investors and hedge funds have also recently modified their holdings of A. Generation Investment Management LLP grew its stake in shares of Agilent Technologies by 19.8% in the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company's stock valued at $582,976,000 after acquiring an additional 824,243 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Agilent Technologies by 15,648.1% in the first quarter. GAMMA Investing LLC now owns 627,247 shares of the medical research company's stock valued at $73,375,000 after acquiring an additional 623,264 shares in the last quarter. Two Sigma Investments LP grew its stake in shares of Agilent Technologies by 345.9% in the fourth quarter. Two Sigma Investments LP now owns 769,897 shares of the medical research company's stock valued at $103,428,000 after acquiring an additional 597,249 shares in the last quarter. Iron Triangle Partners LP acquired a new position in shares of Agilent Technologies in the fourth quarter valued at about $80,110,000. Finally, Mackenzie Financial Corp grew its stake in shares of Agilent Technologies by 141.5% in the first quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company's stock valued at $109,481,000 after acquiring an additional 548,344 shares in the last quarter.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on A shares. TD Cowen upped their price target on shares of Agilent Technologies to $150.00 and gave the company a "buy" rating in a research note on Thursday, May 29th. JPMorgan Chase & Co. reduced their price objective on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research note on Thursday, May 29th. Wall Street Zen downgraded shares of Agilent Technologies from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. UBS Group reduced their price objective on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research note on Thursday, May 29th. Finally, Robert W. Baird increased their price objective on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a research note on Thursday, August 28th. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $139.25.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares of the company's stock, valued at $4,397,893.12. The trade was a 3.87% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Agilent Technologies Trading Up 1.9%

Shares of A stock traded up $2.40 during trading hours on Thursday, hitting $126.52. 620,716 shares of the company were exchanged, compared to its average volume of 1,949,582. The firm has a market cap of $35.87 billion, a P/E ratio of 29.71, a P/E/G ratio of 3.93 and a beta of 1.24. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The company has a 50 day simple moving average of $119.61 and a two-hundred day simple moving average of $116.13.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter last year, the firm posted $1.32 EPS. Agilent Technologies's revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.